Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI and HRQL Outcomes in Autoimmune Patients Switched to EC-MPS
NCT00351377Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate sodium in autoimmune disease, sponsored by Novartis. Started Jun 2006; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
autoimmune disease
Beyond the preview
Go deeper on NCT00351377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351377.